Path ID: DB08949_MESH_D006937_1

db08949-mesh-d006937-1

Concepts

Identifier Name Type
MESH:C005193 Inositol Niacinate Drug
UniProt:P49019 Hydroxycarboxylic acid receptor 3 Protein
UniProt:Q8TDS4 Hydroxycarboxylic acid receptor 2 Protein
reactome:R-HSA-418594 G alpha (i) signalling events Pathway
MESH:D014280 Triglycerides ChemicalSubstance
MESH:D008077 Lipoproteins, LDL ChemicalSubstance
MESH:C032607 low density lipoprotein triglyceride ChemicalSubstance
MESH:D008078 Cholesterol, LDL ChemicalSubstance
MESH:D006937 Hypercholesterolemia Disease

Relationships

NOTE: predicates are annotated in Biolink Model (v1.3.0)

Subject Predicate Object
Inositol Niacinate INCREASES ACTIVITY OF Hydroxycarboxylic Acid Receptor 3
Inositol Niacinate INCREASES ACTIVITY OF Hydroxycarboxylic Acid Receptor 2
Hydroxycarboxylic Acid Receptor 3 PARTICIPATES IN G Alpha (I) Signalling Events
Hydroxycarboxylic Acid Receptor 2 PARTICIPATES IN G Alpha (I) Signalling Events
G Alpha (I) Signalling Events DECREASES ABUNDANCE OF Triglycerides
Triglycerides POSITIVELY CORRELATED WITH Low Density Lipoprotein Triglyceride
Triglycerides POSITIVELY CORRELATED WITH Cholesterol, Ldl
Triglycerides POSITIVELY CORRELATED WITH Lipoproteins, Ldl
Low Density Lipoprotein Triglyceride POSITIVELY CORRELATED WITH Hypercholesterolemia
Cholesterol, Ldl POSITIVELY CORRELATED WITH Hypercholesterolemia
Lipoproteins, Ldl POSITIVELY CORRELATED WITH Hypercholesterolemia

Comment: Other commonly used names for this drug are inositol nicotinate (CHEBI:50134), myo-inositol hexanicotinate (CHEBI:31699) and inositol hexanicotinate (CHEBI:33064)(https://en.wikipedia.org/wiki/Inositol_nicotinate). This drug is made of niacin (vitamin B3, MESH:D009525) and inositol (MESH:D007294. Note the original drug to curate for this disease was inositol but there is no evidence for it to be used as treatment unless it’s bound to nicotinic acid to form inositol hexanicotinate.

Reference: